Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and seeks to commercialize hospital-based therapies for acute life-threatening neurological and other conditions.
Edge Therapeutics, Inc.
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”EDGE” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.edgetherapeutics.com
Founded2009
Disease Focus
Development Stage
STOCK CODENASDAQ: EDGE
Address300 Connell Drive, Suite 4000, NJ 07922Berkeley HeightsUnited States
300 Connell Drive, Suite 4000, NJ 07922
Berkeley Heights
United States
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/edge-therapeutics-inc-” connections=”true” suffix=””]